Metabolix (MBLX) Misses Q2 EPS View By A Penny
More News related to MBLX
- Metabolix (MBLX) Reports Wider Than Expected Q3 Loss
- Metabolix Reports Third Quarter 2008 Financial Results and Provides Business Update
- Reminder - Metabolix to Conduct a Webcast of Its Third Quarter 2008 Earnings Call
- Metabolix Hires to Support Technology Development of Mirel(TM) Bioplastics
- Metabolix Announces that Mirel(TM) Bioplastic Resins are Certified to European Vincotte Biodegradability for Soil and Fresh Water Standards
More News related to Earnings
- Sandler O'Neill Upgrades Wintrust Financial (WTFC) to Hold
- Gabelli & Co. Upgrades Barnes Group (B) to Buy
- Matrix Upgrades/Downgrades for December 1, 2008
- Wall Street Access Upgrades Cummins (CMI) to Buy
- RBC Capital Upgrades Hospitality Properties Trust (HPT) to Outperform
Metabolix, Inc (Nasdaq: MBLX) reports a Q2 loss of $0.39, 1 cent below the analyst estimate of ($0.38). Revenues for the quarter were $400K, versus the consensus of $660K.
Metabolix, Inc., a biotechnology company, develops alternatives to petrochemical-based plastics, chemicals, and energy.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
